Ben A. C. Dijkmans

37.0k citations

332 papers · 25.0k indexed · 7 hit papers · h-index 83

Rheumatology top 0.01%
Immunology top 0.2%
Hematology top 0.05%
Molecular Biology top 2%
Radiology, Nuclear Medicine and Imaging top 0.5%

Co-authors: Michael T. Nurmohamed Alexandre E. Voskuyl Willem F. Lems Dirkjan van Schaardenburg Maarten Boers Désirée van der Heijde Cornelia F Allaart Margret H. M. T. De Koning
Topics: Rheumatoid Arthritis Research and Therapies (190 papers)Systemic Lupus Erythematosus Research (103 papers)Spondyloarthritis Studies and Treatments (57 papers)
Cited by: Rheumatology Hematology Immunology
Journals: New England Journal of Medicine The Lancet Journal of Biological Chemistry
Partner nations: Netherlands United States Germany

In The Last Decade

Ben A. C. Dijkmans

328 papers receiving 24.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy

1991 1.7k citations Sjef van der Linden, A. Cats et al. Arthritis & Rheumatism profile →
Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors

2004 1.4k citations Dirkjan van Schaardenburg, Jan P. Vandenbroucke et al. Arthritis & Rheumatism profile →
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

2005 1.1k citations Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra et al. Arthritis & Rheumatism profile →
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1997 800 citations Maarten Boers, Arco C. Verhoeven et al. profile →
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

2006 660 citations Désirée van der Heijde, Joachim Sieper et al. Arthritis & Rheumatism profile →
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

2005 651 citations Désirée van der Heijde, Ben A. C. Dijkmans et al. Arthritis & Rheumatism profile →
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

2007 448 citations Carla A. Wijbrandts, Michael T. Nurmohamed et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Ben A. C. Dijkmans

Since Specialization

Citations

This map shows the geographic impact of Ben A. C. Dijkmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben A. C. Dijkmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben A. C. Dijkmans more than expected).

Fields of papers citing papers by Ben A. C. Dijkmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben A. C. Dijkmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben A. C. Dijkmans. The network helps show where Ben A. C. Dijkmans may publish in the future.

Co-authorship network of co-authors of Ben A. C. Dijkmans

This figure shows the co-authorship network connecting the top 25 collaborators of Ben A. C. Dijkmans. A scholar is included among the top collaborators of Ben A. C. Dijkmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben A. C. Dijkmans. Ben A. C. Dijkmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Folates and antifolates in rheumatoid arthritis 2013 ·Pteridines ·Gerrit Jansen,Karin Weijers,(unknown),(unknown),Yoony Y. J. Gent,(unknown),(unknown),Carla F.M. Molthoff,Cor L. Verweij,(unknown),Willem F. Lems,Rik J. Scheper,Godefridus J. Peters,Manohar Ratnam,(unknown),Ben A. C. Dijkmans	1
2	Targeting the immunoproteasome with the second generation proteasome inhibitor ONX 0914: effects on IFN-alpha-induced monocyte-derived dendritic cells (119.4) 2012 ·The Journal of Immunology ·Sue Ellen Verbrugge,Diba Emal,(unknown),Sinéad M. Lougheed,Elena T. Chan,Christopher J. Kirk,Ben A. C. Dijkmans,Rik J. Scheper,Tanja D. de Gruijl	2
3	Inactivating PSMB5 Mutations and P-Glycoprotein (Multidrug Resistance-Associated Protein/ATP-Binding Cassette B1) Mediate Resistance to Proteasome Inhibitors: Ex Vivo Efficacy of (Immuno)Proteasome Inhibitors in Mononuclear Blood Cells from Patients with Rheumatoid Arthritis 2012 ·Journal of Pharmacology and Experimental Therapeutics ·Sue Ellen Verbrugge,Yehuda G. Assaraf,Ben A. C. Dijkmans,George L. Scheffer,(unknown),Debby den Uyl,Ruud Oerlemans,Elena T. Chan,Christopher J. Kirk,Godefridus J. Peters,Joost W van der Heijden,Tanja D. de Gruijl,Rik J. Scheper,Gerrit Jansen	87
4	Decreased Recurrence Rate of Anterior Uveitis in Ankylosing Spondylitis Treated with Adalimumab - An Interim Analysis 2010 ·Clinical and Experimental Rheumatology ·Irene E. van der Horst‐Bruinsma,J. Christiaan van Denderen,I.M. Visman,Maria S.A. Suttorp-Schulten,Ben A. C. Dijkmans,Michael T. Nurmohamed	8
5	Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis 2009 ·The Journal of Rheumatology ·Ben A. C. Dijkmans,Paul Emery,Markku Hakala,Marjatta Leirisalo‐Repo,Emilio Martín Mola,L Paolozzi,Carlo Salvarani,Raimón Sanmartí,Jean Sibilia,Joachim Sieper,Filip Van den Bosch,Désirée van der Heijde,Sjef van der Linden,Joseph Wajdula	51
6	Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation 2008 ·Annals of the Rheumatic Diseases ·Vokko P. van Halm,Matthew Peters,Alexandre E. Voskuyl,Maarten Boers,Willem F. Lems,Marjolein Visser,Coen D.A. Stehouwer,Annemieke M. W. Spijkerman,Joost Dekker,Giel Nijpels,R.J. Heine,L.M. Bouter,Yvo M. Smulders,Ben A. C. Dijkmans,Michael T. Nurmohamed	270
7	IFN/TNF cross-regulation in vivo during infliximab treatment in rheumatoid arthritis 2008 ·Arthritis & Rheumatism ·Lisa G. M. van Baarsen,Carla A. Wijbrandts,François Rustenburg,Tineke Cantaert,Tineke C. T. M. van der Pouw Kraan,(unknown),Ben A. C. Dijkmans,Paul P. Tak,Cornelis L. Verweij	1
8	Rheumatoid arthritis as important independent risk factor for incident cardiovascular disease 2008 ·Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) ·Mike J. Peters,Vokko P. van Halm,Alexandre E. Voskuyl,Maarten Boers,Willem F. Lems,(unknown),Coen D.A. Stehouwer,Joost Dekker,Giel Nijpels,L.M. Bouter,Yvo M. Smulders,Ben A. C. Dijkmans,Michael T. Nurmohamed	2
9	Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS) 2008 ·Oxford University Research Archive (ORA) (University of Oxford) ·Désirée van der Heijde,Ben A. C. Dijkmans,(unknown),A. Kivitz,Kurt De Vlam,P Wordsworth,Shaila Ballal,H. Küpper,(unknown),J. Sieper,(unknown)	2
10	Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis. 2007 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Johannes W G Jacobs,R. N. J. de Nijs,Willem F. Lems,Piet Geusens,Roland Laan,(unknown),Ale Algra,Erik Buskens,Lorenz C. Hofbauer,A. Oostveen,George A. W. Bruyn,Ben A. C. Dijkmans,J. W. J. Bijlsma	25
11	Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients 2007 ·Annals of the Rheumatic Diseases ·Tineke C. T. M. van der Pouw Kraan,Carla A. Wijbrandts,Lisa G. M. van Baarsen,Alexandre E. Voskuyl,François Rustenburg,Josefien M. Baggen,Saleh Ibrahim,Mike Fero,Ben A. C. Dijkmans,P. P. Tak,C L Verweij	234
12	Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score 2007 ·Annals of the Rheumatic Diseases ·S M van der Kooij,Jeska K de Vries‐Bouwstra,Y P M Goekoop-Ruiterman,D. van Zeben,P. J. S. M. Kerstens,A. Gerards,J.H.L.M. van Groenendael,Johanna M. W. Hazes,FC Breedveld,(unknown),Ben A. C. Dijkmans	71
13	Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis 2006 ·Obstetrical & Gynecological Survey ·R. N. J. de Nijs,Johannes W. G. Jacobs,Willem F. Lems,Roland Laan,Ale Algra,(unknown),Erik Buskens,Chris De Laet,A. Oostveen,Piet Geusens,George A. W. Bruyn,Ben A. C. Dijkmans,J. W. J. Bijlsma	28
14	Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance–associated protein 1 and provokes high levels of cross‐resistance to glucocorticoids 2006 ·Arthritis & Rheumatism ·Ruud Oerlemans,(unknown),(unknown),Ben A. C. Dijkmans,Gertjan J.L. Kaspers,Willem F. Lems,George L. Scheffer,Ilan Ifergan,Rik J. Scheper,Jacqueline Cloos,Yehuda G. Assaraf,Gerrit Jansen	31
15	Comparison of the baseline disease activity of early oligo- and polyarthritis in sequential years. 2004 ·PubMed ·L M A Jansen,Irene E. van der Horst‐Bruinsma,Dirkjan van Schaardenburg,Leroy R. Lard,Johanna M W Hazes,T. Huizinga,Ben A. C. Dijkmans	6
16	Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis 2004 ·Annals of the Rheumatic Diseases ·Maarten C. Kraan,Tom Smeets,(unknown),F C Breedveld,Ben A. C. Dijkmans,PP Tak	44
17	COBRA combination therapy in patients with early rheumatoid arthritis: Long‐term structural benefits of a brief intervention 2002 ·Arthritis & Rheumatism ·Robert Landewé,Maarten Boers,Arco C. Verhoeven,René Westhovens,Mart A F J van de Laar,H. M. Markusse,J. Christiaan van Denderen,(unknown),André J. Peeters,Ben A. C. Dijkmans,Piet Jacobs,Annelies Boonen,Désirée van der Heijde,Sjef van der Linden	442
18	Low Dose Cyclosporine in Early Rheumatoid Arthritis: Effective and Safe after Two Years of Therapy when Compared with Chloroquine 1996 ·Scandinavian Journal of Rheumatology ·(unknown),R. B. M. Landewé,H. S. Goei Thè,FC Breedveld,Ben A. C. Dijkmans	8
19	Serum Values of Pepsinogens and Antibodies to Helicobacter Pylori in Relation to a History of Peptic Ulcer Disease and NSAID Use 1995 ·Scandinavian Journal of Rheumatology ·M. Janssen,Ben A. C. Dijkmans,Jan P. Vandenbroucke,I. Biemond,(unknown),A. H. Zwinderman,C. B. H. W. Lamers	3
20	Penetration of cyclosporin into synovial fluid in rheumatoid arthritis 1989 ·European Journal of Clinical Pharmacology ·(unknown),Ben A. C. Dijkmans,H. S. Goei Thè,Maarten Boers,A. Cats	5

About Ben A. C. Dijkmans

Ben A. C. Dijkmans is a scholar working on Rheumatology, Hematology and Genetics, having authored 332 papers that have together received 25.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (190 papers), Systemic Lupus Erythematosus Research (103 papers) and Spondyloarthritis Studies and Treatments (57 papers). The work is most often cited by research in Rheumatology (18.3k citations), Hematology (6.1k citations) and Immunology (6.3k citations). Ben A. C. Dijkmans has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Michael T. Nurmohamed, Alexandre E. Voskuyl, Willem F. Lems, Dirkjan van Schaardenburg, Maarten Boers, Désirée van der Heijde, Cornelia F Allaart, Margret H. M. T. De Koning, Jan P. Vandenbroucke and Sjef van der Linden. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact